Open AccessLombardia
Author(s) -
Maria Caterina Cavallo,
Filippo Cipriani,
Simone Gerzeli,
Nadia Demarteau,
Alessia Marocco,
Francesco Bamfi
Publication year - 2008
Publication title -
farmeconomia/farmeconomia e percorsi terapeutici
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v9i1s.1001
Subject(s) - medicine , cohort , vaccination , demography , cohort study , pediatrics , immunology , sociology
In Lombardy region 67,2% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 155 cases of cervicocarcinoma and 65 related deaths and thus results to be cost-effective (27.092 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 142 cancer cases and 61 deaths could be prevented, with a very similar cost-effectiveness ratio. In Lombardy region, the net cost for woman vaccinated is 197 € for the single cohort and 199 € for the multiple cohort